Backed by Main Sequence & CSIRO

Inventia Life Science

Revolutionising 3D cell biology with bioprinting

Inventia Life Science builds bioprinters and formulates bioinks to create human tissue structures for research. Their RASTRUM platform enables high-throughput 3D cell culture that closely imitates real human tissue for cancer research, drug discovery, and regenerative medicine.

Explore InventiaLearn More

RASTRUM: 3D Cell Culture at Scale

The world's first high-throughput 3D bioprinting platform using drop-on-demand technology to print complex, multi-cellular tissue models in standard microplates.

Drop-on-demand bioprinting creates 3D cell structures layer-by-layer in standard microplates

Digital bioink library of tissue-specific formulations for cancer, neuro, and disease models

High-throughput capability enabling scalable, reproducible 3D cell culture for drug discovery

Backed by Main Sequence & CSIRO

Ready to learn more about Inventia Life Science?

Discover how Inventia Life Science is transforming their industry with deep technology innovation.

Explore InventiaView All Portfolio